In a longitudinal study of people with severe asthma receiving the anti-IL-5 monoclonal antibody mepolizumab, elevated serum CRP was a marker of non-eosinophilic exacerbations associated with infections, although these were viral rather than bacterial infections in the majority of cases [156]. Here, IL5 is linked to asthma.